Inhibrx CEO Mark Lappe's 2021 pay jumps 439% to $4.7M
Inhibrx reports 2021 executive compensation
By ExecPay News
Published: April 13, 2022
Inhibrx reported fiscal year 2021 executive compensation information on April 13, 2022.
In 2021, four Inhibrx executives received on average a compensation package of $3.1M, a 306% increase compared to previous year.
Average pay of disclosed executives at Inhibrx
Mark P. Lappe, Chief Executive Officer, received $4.7M in total, which increased by 439% compared to 2020. 79% of Lappe's compensation, or $3.7M, was in option awards. Lappe also received $325K in non-equity incentive plan, $650K in salary, as well as $19K in other compensation.
Klaus W. Wagner, Chief Medical Officer, received a compensation package of $3.7M, which increased by 278% compared to previous year. 83% of the compensation package, or $3.1M, was in option awards.
Kelly D. Deck, Chief Financial Officer, earned $2.2M in 2021, a 280% increase compared to previous year.
Brendan P. Eckelman, Chief Scientific Officer, received $1.7M in 2021, which increases by 182% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 13, 2022.